Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays

Rare tumor-specific mutations in patient samples serve as excellent markers to monitor the course of malignant disease and responses to therapy in clinical routine, and improved assay techniques are needed for broad adoption. We describe herein a highly sensitive and selective molecule amplification...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lei, Eriksson, Anna, Weström, Simone, Pandzic, Tatjana, Lehmann, Sören, Cavelier, Lucia, Landegren, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276831/
https://www.ncbi.nlm.nih.gov/pubmed/35821208
http://dx.doi.org/10.1038/s41467-022-31397-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276831/
https://www.ncbi.nlm.nih.gov/pubmed/35821208
http://dx.doi.org/10.1038/s41467-022-31397-y

Ejemplares similares